Age-related outcomes in MSI/dMMR gastrointestinal cancers treated by immune checkpoint inhibitors and toxicity’s impact on efficacy: an immunoMSI cohort study

Autor: Mailly-Giacchetti, L., Colle, R., Samaille, T., Lopez-Trabada Ataz, D., Faucheux, L., Duval, A., Andre, T., Cohen, R.
Zdroj: In ESMO Gastrointestinal Oncology June 2024 4
Databáze: ScienceDirect